– PubMed studies that discuss the microbiology of autism
===== Patient interviews =====
<html>
<div class=“patientinterviews”>
<html>
<div class=“patientinterviewboxl”>
<div class=“patientinterviewimage”></html><html></div>
<div class=“patientinterviewtext”>
<div class=“patientinterviewname”></html>Doreen V. (patient's mother)<html></div></html>
autism, ADHD, depression, severe anxiety, chronic fatigue syndrome (CFS)
Read the interview
<html></div></div>
<br clear=“left” />
</div>
</html>
Interviews of patients with other diseases are also available.
===== Prodigies, autism, and the interactome =====
As described in Psychology Today, autism and being a prodigy are closely related:
<blockquote>Ruthsatz found that both the first-degree families of individuals with autism and the first-degree families of prodigies in her sample displayed three out of five common traits of autism: impaired social skills, impaired ability to switch attention, and heightened attention to detail. This intrigued her, so she decided to look for autism in her current sample of prodigies.
Lo and behold, while about one in every 88 children in the United States is diagnosed with autism, four out of the eight prodigies in the current study had family members who either had an autism diagnosis or had a first- or second-degree relative with an autism diagnosis. Additionally, three of the prodigies had already been diagnosed with autism, and as a group they showed higher levels of autistic traits compared with a control group consisting of people weren't prodigies (but scored only slightly higher than those with high-functioning autism, or Asperger's.
</blockquote>
This may be a case where the exact interaction among microbes, known as the interactome, may contribute both to illness as well as exceptional cognitive abilities.
===== Read More =====
biological effects
<nodisp>
===== Notes and comments =====
<DiseaseHierarchy>
<blockquote>
Children with autism spectrum disorders (ASD) who exhibit chronic gastrointestinal (GI) symptoms and marked fluctuation of behavioral symptoms exhibit distinct innate immune abnormalities and transcriptional profiles of peripheral blood (PB) monocytes.
Jyonouchi H, Geng L, Streck DL, Toruner GA.
J Neuroimmunol. 2011 Jul 29. [Epub ahead of print]
https://www.sciencedirect.com/science/article/pii/S0165572811001913
Innate/adaptive immune responses and transcript profiles of peripheral blood monocytes were studied in ASD children who exhibit fluctuating behavioral symptoms following infection and other immune insults (ASD/Inf, N=30). The ASD/Inf children with persistent gastrointestinal symptoms (ASD/Inf+GI, N=19), revealed less production of proinflammatory and counter-regulatory cytokinesAny of various protein molecules secreted by cells of the immune system that serve to regulate the immune system. with stimuli of innate immunityThe body's first line of defense against intracellular and other pathogens. According to the Marshall Pathogenesis the innate immune system becomes disabled as patients develop chronic disease. and marked changes in transcript profiles of monocytes as compared to ASD/no-Inf (N=28) and normal (N=26) controls. This included a 4-5 fold up-regulation of chemokines (CCL2 and CCL7), consistent with the production of more CCL2 by ASD/Inf+GI cells. These results indicate dysregulated innate immune defense in the ASD/Inf+GI children, rendering them more vulnerable to common microbial infection/dysbiosis and possibly subsequent behavioral changes.
</blockquote>
<blockquote>“The analysis of more than 600 three-year-olds with an older autistic sibling found that almost one in five of them had an autism spectrum disorder, which includes Asperger's syndrome and similar conditions”
https://www.reuters.com/article/2011/08/15/us-autistic-kids-idUSTRE77E0OW20110815
</blockquote>
<blockquote>
With the exception of fibrotic tissue deposited in the organs by years of disease, we have seen the body exhibit a miraculous ability to heal itself. The adults have recovered their brains, their memories, their cognition, decades of their lives. I don't see why we shouldn't expect the same phenomena of neuro-regeneration in children. There is one child, Matt, who has indeed exhibited such a recovery.
Trevor Marshall, PhD </blockquote>
From Trevor, “Brain autoantibodies found in AUTISM”:
<blockquote>Ann Clin Psychiatry. 2009 Jul-Sep;21(3):148-61.
Phenotypic expression of autoimmuneA condition or disease thought to arise from an overactive immune response of the body against substances and tissues normally present in the body autistic disorder (AAD): a major subset of autism.
Singh VK.
Brain State International Research Center, Scottsdale, AZ 85260, USA.vj1000s@yahoo.com
BACKGROUND: Autism causes incapacitating neurologic problems in children that last a lifetime. The author of this article previously hypothesized that autism may be caused by autoimmunity to the brain, possibly triggered by a viral infection. This article is a summary of laboratory findings to date plus new data in support of an autoimmune pathogenesis for autism. METHODS: Autoimmune markers were analyzed in the sera of autistic and normal children, but the cerebrospinal fluid (CSF) of some autistic children was also analyzed. Laboratory procedures included enzyme-linked immunosorbent assay and protein immunoblotting assay. RESULTS: Autoimmunity was demonstrated by the presence of brain autoantibodies, abnormal viral serology, brain and viral antibodies in CSF, a positive correlation between brain autoantibodies and viral serology, elevated levels of proinflammatory cytokines and acute-phase reactants, and a positive response to immunotherapy. Many autistic children harbored brain myelin basic protein autoantibodies and elevated levels of antibodies to measles virus and measles-mumps-rubella (MMR) vaccine. Measles might be etiologically linked to autism because measles and MMR antibodies (a viral marker) correlated positively to brain autoantibodies (an autoimmune marker)–salient features that characterize autoimmune pathology in autism. Autistic children also showed elevated levels of acute-phase reactants–a marker of systemic inflammationThe complex biological response of vascular tissues to harmful stimuli such as pathogens or damaged cells. It is a protective attempt by the organism to remove the injurious stimuli as well as initiate the healing process for the tissue.. CONCLUSIONS: The scientific evidence is quite credible for our autoimmune hypothesis, leading to the identification of autoimmune autistic disorder (AAD) as a major subset of autism. AAD can be identified by immune tests to determine immune problems before administering immunotherapy. The author has advanced a speculative neuroautoimmune (NAI) model for autism, in which virus-induced autoimmunity is a key player. The latter should be targeted by immunotherapy to help children with autism.
PMID: 19758536</blockquote>
From Amy:
<blockquote>Very interesting. I had also found this study:
https://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TBD-4VB6KTF-B&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_searchStrId=1021423445&_rerunOrigin=google&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=3f27b32cf2776353b0c363891b3fbef5
Autism may involve an autoimmune pathogenesis in a subgroup of patients. The frequency of anti-nuclear antibodies in 80 autistic children and their relationship to a family history of autoimmunity were studied, compared with 80 healthy, matched children. Children with autism had a significantly higher percent seropositivity of anti-nuclear antibodies (20%) than healthy children (2.5%; P < 0.01). Fifty percent of anti-nuclear antibody-seropositive autistic children had an anti-nuclear antibody titer of ≥1:640 (very high positive); 25%, ≥1:160 (high positive); and the remaining 25%, 1:80. All anti-nuclear antibody-seropositive healthy children had anti-nuclear antibody titers of 1:80. A family history of autoimmunity was significantly higher in autistic children (47.5%) than healthy controls (8.8%; P < 0.001). Anti-nuclear antibody seropositivity was significantly higher in autistic children with a family history of autoimmunity than those without such history (36.8% and 5%, respectively; P < 0.001). Anti-nuclear antibody seropositivity had significant positive associations with disease severity, mental retardation and electroencephalogram abnormalities. Autoimmunity may play a role in a subgroup of children with autism. Further studies are warranted to assess anti-nuclear antibody seropositivity, other markers of autoimmunity (e.g., brain-specific autoantibodies), and the role of immunotherapy in children with autism.</blockquote>
From Trevor:
<blockquote>“Misfolded Proteins Linked to Autism Disorders”
https://www.medicalnewstoday.com/articles/200742.php
This lines up with research described at DMM2008, where it was revealed that Prions were only infectious in the presence of a chronic inflammatory disease. It seems that there are a lot of misfolded proteins, not just prions, which result from the inflammatory disease process.
</blockquote>
Singh, V. K. (2009). “Phenotypic expression of autoimmune autistic disorder (AAD): a major subset of autism.” Ann Clin Psychiatry 21(3): 148-161.
19758536
BACKGROUND: Autism causes incapacitating neurologic problems in children that last a lifetime. The author of this article previously hypothesized that autism may be caused by autoimmunity to the brain, possibly triggered by a viral infection. This article is a summary of laboratory findings to date plus new data in support of an autoimmune pathogenesis for autism. METHODS: Autoimmune markers were analyzed in the sera of autistic and normal children, but the cerebrospinal fluid (CSF) of some autistic children was also analyzed. Laboratory procedures included enzyme-linked immunosorbent assay and protein immunoblotting assay. RESULTS: Autoimmunity was demonstrated by the presence of brain autoantibodies, abnormal viral serology, brain and viral antibodies in CSF, a positive correlation between brain autoantibodies and viral serology, elevated levels of proinflammatory cytokines and acute-phase reactants, and a positive response to immunotherapy. Many autistic children harbored brain myelin basic protein autoantibodies and elevated levels of antibodies to measles virus and measles-mumps-rubella (MMR) vaccine. Measles might be etiologically linked to autism because measles and MMR antibodies (a viral marker) correlated positively to brain autoantibodies (an autoimmune marker)–salient features that characterize autoimmune pathology in autism. Autistic children also showed elevated levels of acute-phase reactants–a marker of systemic inflammation. CONCLUSIONS: The scientific evidence is quite credible for our autoimmune hypothesis, leading to the identification of autoimmune autistic disorder (AAD) as a major subset of autism. AAD can be identified by immune tests to determine immune problems before administering immunotherapy. The author has advanced a speculative neuroautoimmune (NAI) model for autism, in which virus-induced autoimmunity is a key player. The latter should be targeted by immunotherapy to help children with autism.
Mostafa, G. A. and N. Kitchener (2009). “Serum anti-nuclear antibodies as a marker of autoimmunity in Egyptian autistic children.” Pediatr Neurol 40(2): 107-112.
19135624
Autism may involve an autoimmune pathogenesis in a subgroup of patients. The frequency of anti-nuclear antibodies in 80 autistic children and their relationship to a family history of autoimmunity were studied, compared with 80 healthy, matched children. Children with autism had a significantly higher percent seropositivity of anti-nuclear antibodies (20%) than healthy children (2.5%; P < 0.01). Fifty percent of anti-nuclear antibody-seropositive autistic children had an anti-nuclear antibody titer of > or =1:640 (very high positive); 25%, > or =1:160 (high positive); and the remaining 25%, 1:80. All anti-nuclear antibody-seropositive healthy children had anti-nuclear antibody titers of 1:80. A family history of autoimmunity was significantly higher in autistic children (47.5%) than healthy controls (8.8%; P < 0.001). Anti-nuclear antibody seropositivity was significantly higher in autistic children with a family history of autoimmunity than those without such history (36.8% and 5%, respectively; P < 0.001). Anti-nuclear antibody seropositivity had significant positive associations with disease severity, mental retardation and electroencephalogram abnormalities. Autoimmunity may play a role in a subgroup of children with autism. Further studies are warranted to assess anti-nuclear antibody seropositivity, other markers of autoimmunity (e.g., brain-specific autoantibodies), and the role of immunotherapy in children with autism.
* Legacy content
* https://www.marshallprotocol.com/view_topic.php?id=1263&forum_id=32&jump_to=64344#p64344 f13
<blockquote>J Child Neurol. 2006 Jun;21(6):444-9.High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression.
Sokol DK, Chen D, Farlow MR, Dunn DW, Maloney B, Zimmer JA, Lahiri DK.
Department of Neurology, Indiana University School of Medicine, 702 Barnhill Drive, Indianapolis, IN 46202, USA. dksokol@iupui.edu
Abstract
Autism is characterized by restricted, repetitive behaviors and impairment in socialization and communication. Although no neuropathologic substrate underlying autism has been found, the findings of brain overgrowth via neuroimaging studies and increased levels of brain-derived neurotrophic factor (BDNF) in neuropathologic and blood studies favor an anabolic state. We examined acetylcholinesterase, plasma neuronal proteins, secreted beta-amyloid precursor protein (APP), and amyloid-beta 40 and amyloid-beta 42 peptides in children with and without autism. Children with severe autism and aggression expressed secreted beta-amyloid precursor protein at two or more times the levels of children without autism and up to four times more than children with mild autism. There was a trend for children with autism to show higher levels of secreted beta-amyloid precursor protein and nonamyloidogenic secreted beta-amyloid precursor protein and lower levels of amyloid-beta 40 compared with controls. This favors an increased alpha-secretase pathway in autism (anabolic), opposite to what is seen in Alzheimer disease. Additionally, a complex relationship between age, acetylcholinesterase, and plasma neuronal markers was found.
PMID: 16948926
</blockquote>
<blockquote>Ear infections and autism
Readers of this thread will know that I have suggested that my son’s apparent regressive autism at age 20 months was precipitated by an ear infection (otitis media). I wrote a few posts on this some time back and Trevor has indicated that too many beta-lactam antibiotics (e.g. penicillin) can cause bacteria to morph into more virulent L-formsDifficult-to-culture bacteria that lack a cell wall and are not detectable by traditional culturing processes. Sometimes referred to as cell wall deficient bacteria. and cause a pathogenic microbiota to develop in a person. This could explain why some infants suffer a severe and apparently sudden regression after being given too much penicillin as infants to treat ear infections which is standard medical practice for treating such ear infections. Amy has written on this too.
I would not, however, restrict a theory to explain the aetiology of autism to solely this - too much vitamin D in infant formula as well as an acquired microbiota from parents and/or siblings or pets needs to be thrown into the mix of factors (as has been discussed on this thread).
I want to bring folks attention to a recent study that purports to demonstrate that the traditional practice of prescribing antibiotics to infants is to be generally supported see https://www.nejm.org/doi/pdf/10.1056/NEJMoa0912254.
This study was done to address the concerns that abxs are being over-prescribed to infants when viral infections could be causal rather than bacteria and the worry about more bacteria-resistant species being created by over‑prescription.
This study shows no awareness of the issue raised by others before us that over-prescription could be causing cases of ASD. It was actually a mother of an autistic child, Ellen Bolte, who first raised a concern that her son’s autistic regression occurred after frequent courses of antibiotics produced diarrhoea in her son before catastrophic ASD set in. The NEJM study acknowledges that diarrhoea is routinely observed in many children given abxs for OM. Indeed, 6 children in the study group were taken off the abx protocol because of this – the children contracted a clostridium dificile infection. I wonder if any of these children became autistic.
Bolte speculated that the gut’s protective microflora can be disturbed by abxs and this could permit even more virulent clostridia than clostridium dificile bacteria to multiply and possibly cause ASD through a gut-brain connection – see https://www.ncbi.nlm.nih.gov/pubmed/9881820.
Bolte’s idea was taken up by Sidney Finegold who has many Pub med citations (see https://www.ncbi.nlm.nih.gov/pubmed/20603222
https://www.ncbi.nlm.nih.gov/pubmed/17904761 and
https://www.ncbi.nlm.nih.gov/pubmed/12173102
I believe Finegold is an eminent microbiologist who is still pursuing this idea since the late 1990s when Bolte’s paper was first published.
In addition to this, a PubMed paper by Joan Fallon also discussed a possible link between Augmentin, the abx used in the NEJM study, and autism see https://www.ncbi.nlm.nih.gov/pubmed/15607562
None of these papers were cited in the NEJM study. I grant that these papers are about speculations as to a possible link between abx administration and autism rather than established fact. Nonetheless, I think it is pretty poor for the NEJM authors not to have acknowledged these studies (to say nothing of an MP view of the causes of ASD).
Regrettably, none of these studies have an awareness of the Marshall concept of a pathogenic microbiota disrupting vitamin D metabolism and thence gene expression and thence ASD.
Incidentally, one child of the 12 studied by Andrew Wakefield who developed regressive ASD and gastrointestinal disease as infants in his ‘controversial’ study did so after an ear infection as compared to the MMR jab.
John
</blockquote>
<blockquote>
Nature. 2011 May 25. [Epub ahead of print]Transcriptomic analysis of autistic brain reveals convergent molecular pathology.
Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH.
Source
Program in Neurogenetics and Neurobehavioral Genetics, Department of Neurology and Semel Institute, David Geffen School of Medicine, University of California, Los Angeles, California 90095-1769, USA.
Abstract
Autism spectrum disorder (ASD) is a common, highly heritable neurodevelopmental condition characterized by marked genetic heterogeneity. Thus, a fundamental question is whether autism represents an aetiologically heterogeneous disorder in which the myriad genetic or environmental risk factors perturb common underlying molecular pathways in the brain. Here, we demonstrate consistent differences in transcriptome organization between autistic and normal brain by gene co-expression network analysis. Remarkably, regional patterns of gene expression that typically distinguish frontal and temporal cortex are significantly attenuated in the ASD brain, suggesting abnormalities in cortical patterning. We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1 (also known as FOX1), and a module enriched for immune genes and glial markers. Using high-throughput RNA sequencing we demonstrate dysregulated splicing of A2BP1-dependent alternative exons in the ASD brain. Moreover, using a published autism genome-wide association study (GWAS) data set, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism. In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic aetiology for this process. Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.
PMID: 21614001
</blockquote>
<blockquote>Identical twins reveal role of environmental factors in autism
https://bit.ly/nMpHAp</blockquote>
===== References =====</nodisp>